Diabetes  	Diabetes  	 JJ	B-NP
care  	care  	 NN	I-NP
in  	in  	 IN	O
a  	a  	 DT	O
predominantly  	predominantly  	 JJ	O
Native  	Native  	 NNP	B-NP
Hawaiian  	Hawaiian  	 NNP	I-NP
and  	and  	 CC	O
Pacific  	Pacific  	 NNP	B-NP
Islander  	Islander  	 NNP	I-NP
outpatient  	outpatient  	 NN	I-NP
population  	population  	 NN	I-NP
Racial  	Racial  	 JJ	I-NP
differences  	differences  	 NNS	I-NP
in  	in  	 IN	O
diabetes  	diabetes  	 JJ	B-NP
care  	care  	 NN	I-NP
and  	and  	 CC	O
outcomes 	outcomes 	 NNS	O
,  	,  	 ,	O
particularly  	particularly  	 RB	O
among  	among  	 IN	O
African  	African  	 NNP	O
Americans  	Americans  	 NNPS	B-NP
and  	and  	 CC	O
Hispanics 	Hispanics 	 NNPS	B-NP
,  	,  	 ,	O
have  	have  	 VBP	O
been  	been  	 VBN	O
well-recognized 	well-recognized 	 JJ	O
.  	.  	 .	O
The  	The  	 DT	O
goal  	goal  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
study  	study  	 NN	O
was  	was  	 VBD	O
to  	to  	 TO	O
evaluate  	evaluate  	 VB	O
the  	the  	 DT	O
quality  	quality  	 NN	O
of  	of  	 IN	O
diabetes  	diabetes  	 JJ	B-NP
care 	care 	 NN	I-NP
,  	,  	 ,	O
using  	using  	 VBG	O
nationally  	nationally  	 RB	O
recognized  	recognized  	 VBN	B-NP
standards  	standards  	 NNS	I-NP
of  	of  	 IN	O
care 	care 	 NN	O
,  	,  	 ,	O
in  	in  	 IN	O
a  	a  	 DT	O
multispecialty 	multispecialty 	 NN	B-NP
,  	,  	 ,	O
hospital-based  	hospital-based  	 JJ	O
clinic  	clinic  	 NN	O
that  	that  	 WDT	O
cares  	cares  	 VBZ	O
for  	for  	 IN	O
a  	a  	 DT	O
predominantly  	predominantly  	 JJ	O
Native  	Native  	 NNP	B-NP
Hawaiian  	Hawaiian  	 NNP	I-NP
and  	and  	 CC	O
Pacific  	Pacific  	 NNP	B-NP
Islander  	Islander  	 NNP	I-NP
population 	population 	 NN	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
identified  	identified  	 VBD	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
a  	a  	 DT	O
new  	new  	 JJ	O
primary  	primary  	 JJ	O
or  	or  	 CC	O
secondary  	secondary  	 JJ	B-NP
diagnosis  	diagnosis  	 NN	I-NP
of  	of  	 IN	O
diabetes  	diabetes  	 NN	O
during  	during  	 IN	O
a  	a  	 DT	O
visit  	visit  	 NN	O
( 	( 	 -LRB-	O
baseline  	baseline  	 NN	B-NP
visit 	visit 	 NN	I-NP
)  	)  	 -RRB-	O
between  	between  	 IN	O
January  	January  	 NNP	O
2005  	2005  	 CD	O
and  	and  	 CC	O
June  	June  	 NNP	O
2006  	2006  	 CD	O
at  	at  	 IN	O
the  	the  	 DT	O
Queen  	Queen  	 NNP	O
Emma  	Emma  	 NNP	O
Clinics 	Clinics 	 NNP	O
.  	.  	 .	O
Each  	Each  	 DT	O
patient 	patient 	 NN	O
's  	's  	 POS	O
medical  	medical  	 JJ	B-NP
record  	record  	 NN	I-NP
was  	was  	 VBD	O
reviewed  	reviewed  	 VBN	O
to  	to  	 TO	O
obtain  	obtain  	 VB	O
demographic  	demographic  	 JJ	B-NP
and  	and  	 CC	O
clinical  	clinical  	 JJ	B-NP
information  	information  	 NN	I-NP
related  	related  	 VBN	O
to  	to  	 TO	O
diabetes 	diabetes 	 NN	O
,  	,  	 ,	O
including  	including  	 VBG	B-NP
laboratory  	laboratory  	 NN	I-NP
and  	and  	 CC	O
test  	test  	 NN	B-NP
results  	results  	 NNS	I-NP
and  	and  	 CC	O
medications 	medications 	 NN	O
,  	,  	 ,	O
from  	from  	 IN	O
the  	the  	 DT	O
baseline  	baseline  	 NN	B-NP
visit  	visit  	 NN	I-NP
through  	through  	 IN	O
12  	12  	 CD	O
months  	months  	 NNS	O
follow-up 	follow-up 	 JJ	O
.  	.  	 .	O
Performance  	Performance  	 NN	B-NP
indicators  	indicators  	 NNS	I-NP
were  	were  	 VBD	O
selected  	selected  	 VBN	O
from  	from  	 IN	O
those  	those  	 DT	O
recommended  	recommended  	 VBN	O
by  	by  	 IN	O
the  	the  	 DT	O
National  	National  	 NNP	B-NP
Diabetes  	Diabetes  	 NNP	I-NP
Quality  	Quality  	 NNP	I-NP
Improvement  	Improvement  	 NNP	I-NP
Alliance  	Alliance  	 NNP	I-NP
and  	and  	 CC	O
included  	included  	 VBD	O
selected  	selected  	 VBN	O
8  	8  	 CD	O
measures 	measures 	 NNS	O
:  	:  	 :	O
1 	1 	 LS	O
)  	)  	 -RRB-	O
Hemoglobin  	Hemoglobin  	 NNP	O
A1c  	A1c  	 NNP	O
≥9.0 	≥9.0 	 NNP	O
% 	% 	 NN	O
;  	;  	 :	O
2 	2 	 LS	O
)  	)  	 -RRB-	O
Annual  	Annual  	 JJ	O
lipid  	lipid  	 JJ	O
panel  	panel  	 NN	O
checked 	checked 	 NNS	O
;  	;  	 :	O
3 	3 	 LS	O
)  	)  	 -RRB-	O
Systolic  	Systolic  	 NNP	B-NP
blood  	blood  	 NN	I-NP
pressure  	pressure  	 NN	I-NP
< 	< 	 SYM	O
140  	140  	 CD	O
mmHg 	mmHg 	 NN	B-NP
;  	;  	 :	O
4 	4 	 LS	O
)  	)  	 -RRB-	O
LDL  	LDL  	 NNP	B-NP
cholesterol  	cholesterol  	 NN	I-NP
< 	< 	 SYM	O
130  	130  	 CD	O
mg 	mg 	 CD	B-NP
/ 	/ 	 CD	I-NP
dL 	dL 	 NN	I-NP
)  	)  	 -RRB-	O
5 	5 	 CD	O
)  	)  	 -RRB-	O
Annual  	Annual  	 JJ	O
fundoscopic  	fundoscopic  	 JJ	O
examination 	examination 	 NN	O
;  	;  	 :	O
6 	6 	 CD	O
)  	)  	 -RRB-	O
Foot  	Foot  	 NNP	O
examination 	examination 	 NN	O
;  	;  	 :	O
7 	7 	 CD	O
)  	)  	 -RRB-	O
Aspirin  	Aspirin  	 NNP	O
use 	use 	 NN	O
;  	;  	 :	O
8 	8 	 CD	O
)  	)  	 -RRB-	O
Annual  	Annual  	 JJ	O
evaluation  	evaluation  	 NN	O
for  	for  	 IN	O
urine  	urine  	 JJ	B-NP
protein 	protein 	 NN	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
identified  	identified  	 VBD	O
364  	364  	 CD	O
patients 	patients 	 NNS	O
,  	,  	 ,	O
the  	the  	 DT	O
majority  	majority  	 NN	O
Pacific  	Pacific  	 NNP	B-NP
Islanders  	Islanders  	 NNPS	I-NP
( 	( 	 -LRB-	O
58 	58 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
with  	with  	 IN	O
Asians  	Asians  	 NNPS	B-NP
( 	( 	 -LRB-	O
15 	15 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
Native  	Native  	 NNP	B-NP
Hawaiians  	Hawaiians  	 NNP	I-NP
( 	( 	 -LRB-	O
17 	17 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
more  	more  	 JJR	O
frequent  	frequent  	 JJ	O
than  	than  	 IN	O
Caucasians  	Caucasians  	 NNP	B-NP
( 	( 	 -LRB-	O
10 	10 	 CD	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Compared  	Compared  	 VBN	O
with  	with  	 IN	O
Caucasians 	Caucasians 	 NNP	B-NP
,  	,  	 ,	O
Native  	Native  	 NNP	B-NP
Hawaiians  	Hawaiians  	 NNP	I-NP
and  	and  	 CC	O
Pacific  	Pacific  	 NNP	B-NP
Islanders  	Islanders  	 NNPS	I-NP
were  	were  	 VBD	O
significantly  	significantly  	 RB	O
more  	more  	 RBR	O
likely  	likely  	 JJ	O
to  	to  	 TO	O
have  	have  	 VB	O
poor  	poor  	 JJ	O
glucose  	glucose  	 JJ	B-NP
control 	control 	 NN	I-NP
.  	.  	 .	O
There  	There  	 EX	O
were  	were  	 VBD	O
no  	no  	 DT	O
significant  	significant  	 JJ	O
differences  	differences  	 NNS	O
between  	between  	 IN	O
groups  	groups  	 NNS	O
for  	for  	 IN	O
the  	the  	 DT	O
other  	other  	 JJ	O
measures 	measures 	 NNS	O
.  	.  	 .	O
Patients  	Patients  	 NNS	O
compared  	compared  	 VBN	O
favorably  	favorably  	 RB	O
when  	when  	 WRB	O
compared  	compared  	 VBN	O
with  	with  	 IN	O
national  	national  	 JJ	O
benchmarks 	benchmarks 	 NNS	O
.  	.  	 .	O
For  	For  	 IN	O
2  	2  	 CD	O
indicators 	indicators 	 NNS	O
,  	,  	 ,	O
adherence  	adherence  	 NN	O
was  	was  	 VBD	O
significantly  	significantly  	 RB	O
higher  	higher  	 JJR	O
for  	for  	 IN	O
the  	the  	 DT	O
total  	total  	 JJ	B-NP
study  	study  	 NN	I-NP
population  	population  	 NN	I-NP
compared  	compared  	 VBN	O
with  	with  	 IN	O
the  	the  	 DT	O
US  	US  	 NNP	O
average  	average  	 NN	O
( 	( 	 -LRB-	O
systolic  	systolic  	 JJ	B-NP
blood  	blood  	 NN	I-NP
pressure  	pressure  	 NN	I-NP
< 	< 	 SYM	O
140  	140  	 CD	O
mmHg 	mmHg 	 NN	B-NP
,  	,  	 ,	O
aspirin  	aspirin  	 JJ	O
therapy 	therapy 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
For  	For  	 IN	O
2  	2  	 CD	O
indicators 	indicators 	 NNS	O
,  	,  	 ,	O
there  	there  	 EX	O
were  	were  	 VBD	O
no  	no  	 DT	O
significant  	significant  	 JJ	O
difference  	difference  	 NN	O
( 	( 	 -LRB-	O
LDL  	LDL  	 NNP	B-NP
cholesterol  	cholesterol  	 NN	I-NP
< 	< 	 SYM	O
130  	130  	 CD	O
mg 	mg 	 CD	B-NP
/ 	/ 	 CD	I-NP
dL 	dL 	 NN	I-NP
,  	,  	 ,	O
annual  	annual  	 JJ	O
foot  	foot  	 NN	B-NP
exam 	exam 	 NN	I-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
for  	for  	 IN	O
2  	2  	 CD	O
indicators 	indicators 	 NNS	O
,  	,  	 ,	O
adherence  	adherence  	 NN	O
was  	was  	 VBD	O
significantly  	significantly  	 RB	O
lower  	lower  	 JJR	O
for  	for  	 IN	O
the  	the  	 DT	O
study  	study  	 NN	B-NP
population  	population  	 NN	I-NP
( 	( 	 -LRB-	O
hemoglobin  	hemoglobin  	 CD	O
A1c  	A1c  	 CD	O
> 	> 	 CD	O
9 	9 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
annual  	annual  	 JJ	O
fundoscopic  	fundoscopic  	 JJ	B-NP
examination 	examination 	 NN	I-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Native  	Native  	 NNP	B-NP
Hawaiians  	Hawaiians  	 NNP	I-NP
and  	and  	 CC	O
Pacific  	Pacific  	 NNP	B-NP
Islanders  	Islanders  	 NNPS	I-NP
with  	with  	 IN	O
diabetes  	diabetes  	 NNS	O
have  	have  	 VBP	O
poorer  	poorer  	 JJR	O
blood  	blood  	 NN	B-NP
glucose  	glucose  	 NNS	I-NP
control  	control  	 VBP	O
compared  	compared  	 VBN	O
with  	with  	 IN	O
Caucasians  	Caucasians  	 NNP	B-NP
and  	and  	 CC	O
Asians 	Asians 	 NNPS	B-NP
,  	,  	 ,	O
but  	but  	 CC	O
the  	the  	 DT	O
overall  	overall  	 JJ	O
care  	care  	 NN	O
is  	is  	 VBZ	O
otherwise  	otherwise  	 RB	O
generally  	generally  	 RB	O
similar 	similar 	 JJ	O
.  	.  	 .	O
The  	The  	 DT	O
diabetes  	diabetes  	 NN	B-NP
care  	care  	 NN	I-NP
received  	received  	 VBD	O
by  	by  	 IN	O
patients  	patients  	 NNS	O
in  	in  	 IN	O
this  	this  	 DT	O
clinic  	clinic  	 NN	O
that  	that  	 WDT	O
treats  	treats  	 VBZ	O
a  	a  	 DT	O
generally  	generally  	 RB	O
underserved  	underserved  	 JJ	B-NP
population  	population  	 NN	I-NP
compares  	compares  	 VBZ	O
favorably  	favorably  	 RB	O
with  	with  	 IN	O
national  	national  	 JJ	O
benchmarks 	benchmarks 	 NNS	O
.  	.  	 .	O
